Share this:
A joint research team of POSTECH, The Catholic University, and City University of Hong Kong developed an ‘in vivo priming’ with heart-derived bioink. Using engineered stem cells and 3D bioprinting technology, they began developing medicines for cardiovascular diseases.
This article was first featured at https://ift.tt/2UsSn8H on March 30, 2020 at 11:25AM by
More Stories
Can this possibly be true? “Metal 3D printing is now possible on any 3D printer…with the right settings and a few minor upgrades like a hardened steel nozzle…” – July 2 2023 at 04:59PM
New NASA Funding Ignites 25 3D Printing Projects in Space Exploration – June 18 2023 at 04:34PM
Nvidia AI produces 3D models from 2D videos 3D printing applications forthcoming? – June 15 2023 at 02:55AM